BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 867 filers reported holding BAXTER INTL INC in Q3 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $14,109 | -28.7% | 421,788 | -8.9% | 0.03% | -26.8% |
Q1 2024 | $19,791 | +11.6% | 463,058 | +0.9% | 0.04% | +2.5% |
Q4 2023 | $17,737 | -2.4% | 458,785 | -4.8% | 0.04% | -9.1% |
Q3 2023 | $18,181 | -18.4% | 481,745 | -1.5% | 0.04% | -12.0% |
Q2 2023 | $22,278 | +6.5% | 488,992 | -5.2% | 0.05% | +2.0% |
Q1 2023 | $20,916 | -21.7% | 515,682 | -1.6% | 0.05% | -25.8% |
Q4 2022 | $26,699 | -99.9% | 523,821 | -2.4% | 0.07% | -12.0% |
Q3 2022 | $28,898,000 | -16.8% | 536,548 | -0.8% | 0.08% | -11.8% |
Q2 2022 | $34,731,000 | -18.3% | 540,730 | -1.3% | 0.08% | -2.3% |
Q1 2022 | $42,493,000 | -9.5% | 548,017 | +0.2% | 0.09% | -4.4% |
Q4 2021 | $46,939,000 | +5.5% | 546,817 | -1.2% | 0.09% | -3.2% |
Q3 2021 | $44,509,000 | -3.1% | 553,390 | -3.0% | 0.09% | -2.1% |
Q2 2021 | $45,937,000 | -8.7% | 570,652 | -4.3% | 0.10% | -11.1% |
Q1 2021 | $50,300,000 | -0.5% | 596,391 | -5.4% | 0.11% | -1.8% |
Q4 2020 | $50,569,000 | -6.4% | 630,222 | -6.2% | 0.11% | -16.0% |
Q3 2020 | $54,045,000 | -7.1% | 672,037 | -0.6% | 0.13% | -10.3% |
Q2 2020 | $58,204,000 | +3.7% | 675,999 | -2.3% | 0.15% | -14.1% |
Q1 2020 | $56,151,000 | -5.4% | 691,605 | -2.6% | 0.17% | +23.2% |
Q4 2019 | $59,379,000 | -8.0% | 710,105 | -3.7% | 0.14% | -15.3% |
Q3 2019 | $64,525,000 | +6.2% | 737,685 | -0.6% | 0.16% | +5.8% |
Q2 2019 | $60,782,000 | -3.1% | 742,147 | -3.8% | 0.15% | -3.1% |
Q1 2019 | $62,751,000 | +19.9% | 771,755 | -2.9% | 0.16% | +7.4% |
Q4 2018 | $52,316,000 | -15.7% | 794,831 | -1.2% | 0.15% | +2.1% |
Q3 2018 | $62,038,000 | +2.4% | 804,754 | -1.9% | 0.14% | -2.0% |
Q2 2018 | $60,569,000 | +6.6% | 820,269 | -6.1% | 0.15% | +7.2% |
Q1 2018 | $56,827,000 | -0.3% | 873,720 | -0.9% | 0.14% | +2.2% |
Q4 2017 | $57,018,000 | +3.0% | 882,089 | 0.0% | 0.14% | -2.2% |
Q3 2017 | $55,351,000 | +3.3% | 882,089 | -0.3% | 0.14% | +0.7% |
Q2 2017 | $53,581,000 | +16.0% | 885,051 | -0.6% | 0.14% | +16.1% |
Q1 2017 | $46,173,000 | +10.7% | 890,347 | -5.4% | 0.12% | +8.3% |
Q4 2016 | $41,713,000 | +0.2% | 940,754 | +7.6% | 0.11% | -0.9% |
Q3 2016 | $41,609,000 | -2.4% | 874,136 | -7.3% | 0.11% | -1.8% |
Q2 2016 | $42,652,000 | +10.1% | 943,216 | +0.0% | 0.11% | +9.8% |
Q1 2016 | $38,730,000 | +7.7% | 942,803 | +0.0% | 0.10% | +7.4% |
Q4 2015 | $35,965,000 | +16.2% | 942,723 | +0.0% | 0.10% | +9.2% |
Q3 2015 | $30,964,000 | -55.6% | 942,584 | -5.4% | 0.09% | -51.9% |
Q2 2015 | $69,712,000 | +0.1% | 996,888 | -2.0% | 0.18% | +2.3% |
Q1 2015 | $69,669,000 | -53.6% | 1,017,064 | -50.4% | 0.18% | -6.8% |
Q4 2014 | $150,148,000 | +103.2% | 2,048,694 | +98.9% | 0.19% | -2.1% |
Q3 2014 | $73,908,000 | -1.8% | 1,029,787 | -1.1% | 0.19% | -1.0% |
Q2 2014 | $75,284,000 | -4.8% | 1,041,267 | -3.1% | 0.20% | -5.8% |
Q1 2014 | $79,078,000 | +1.5% | 1,074,727 | -4.0% | 0.21% | +3.0% |
Q4 2013 | $77,894,000 | -0.5% | 1,119,974 | -6.0% | 0.20% | -6.0% |
Q3 2013 | $78,295,000 | -8.4% | 1,191,893 | -3.5% | 0.22% | -10.8% |
Q2 2013 | $85,515,000 | – | 1,234,517 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |